US Stock MarketDetailed Quotes

PRME Prime Medicine

Watchlist
  • 3.300
  • -0.040-1.20%
Close Nov 27 16:00 ET
  • 3.320
  • +0.020+0.61%
Post 18:59 ET
432.83MMarket Cap-1601P/E (TTM)

About Prime Medicine Company

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.

Company Profile

SymbolPRME
Company NamePrime Medicine
Listing DateOct 20, 2022
Issue Price17.00
Founded2019
CEODr. Keith Gottesdiener, M.D.
MarketNASDAQ
Employees234
Fiscal Year Ends12-31
Address60 First Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02141-2300
Phone1-617-564-0013
Websitehttp://www.primemedicine.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Keith Gottesdiener, M.D.
  • President, Chief Executive Officer and Director
  • 5.40M
  • Dr. Allan Reine, M.D.
  • Chief Financial Officer
  • --
  • Carman Alenson
  • Senior Vice President, Finance and Chief Accounting Officer
  • --
  • Richard H. Brudnick
  • Chief Business Officer
  • --
  • Dr. Ann L. Lee, PhD
  • Chief Technical Officer
  • 2.26M
  • Dr. Jeremy Duffield
  • Chief Scientific Officer
  • 2.26M
  • Dr. Meredith Goldwasser
  • Senior Vice President, Strategy and Corporate Operations
  • --
  • Jeffrey D. Marrazzo
  • Director
  • 942.48K
  • Dr. Thomas Cahill
  • Independent Director
  • 451.96K
  • Dr. Wendy K. Chung, M.D.,PhD
  • Independent Director
  • 451.96K
  • Dr. David P. Schenkein, M.D.
  • Independent Director
  • 455.46K
  • Michael A Kelly
  • Independent Director
  • 454.46K
  • Robert Taylor Nelsen
  • Independent Director
  • 445.46K
  • Kaye Foster
  • Independent Director
  • 451.46K
  • Andrew Anzalone, M.D.,PhD
  • Head of Prime Editing Platform
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data